Insider Transactions in Q2 2023 at Intellia Therapeutics, Inc. (NTLA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Eliana Clark EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.97%
|
$225,000
$45.0 P/Share
|
|
Jun 20
2023
|
Eliana Clark EVP, Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.07%
|
$60,000
$12.27 P/Share
|
|
Jun 14
2023
|
Frank Verwiel |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+27.41%
|
-
|
|
Jun 14
2023
|
William J Chase |
BUY
Grant, award, or other acquisition
|
Direct |
1,673
+8.11%
|
-
|
|
Jun 14
2023
|
Fred E Cohen |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+9.59%
|
-
|
|
Jun 14
2023
|
John F Crowley Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+27.41%
|
-
|
|
Jun 14
2023
|
Jesse Goodman |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+27.41%
|
-
|
|
Jun 14
2023
|
Georgia Keresty |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+21.51%
|
-
|
|
Jun 14
2023
|
Muna Bhanji |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+23.51%
|
-
|
|
Apr 14
2023
|
William J Chase |
BUY
Grant, award, or other acquisition
|
Direct |
10,483
+37.75%
|
-
|